feed,title,long_url,short_url
SeekingAlpha,"BioAtla's FDA Fast-Tracked Drug Candidate Boosts Its Oncology Prospects, Speculative Buy",https://seekingalpha.com/article/4725560,
SeekingAlpha,Vista Outdoor's Saga May Finally End At $45 (Rating Downgrade),https://seekingalpha.com/article/4725559,
